Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
about
Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteinsLens epithelium-derived growth factor deSumoylation by Sumo-specific protease-1 regulates its transcriptional activation of small heat shock protein and the cellular responseActivation of mammalian DNA ligase I through phosphorylation by casein kinase IIPhosphorylation negatively regulates the function of coactivator PC4Mapping of the human casein kinase II catalytic subunit genes: two loci carrying the homologous sequences for the alpha subunitThe human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding proteinPhosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLKcDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypesCoding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemiaSpecific phosphorylation of the acidic central region of the N-myc protein by casein kinase IICooperation between small nuclear RNA-activating protein complex (SNAPC) and TATA-box-binding protein antagonizes protein kinase CK2 inhibition of DNA binding by SNAPCComparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C proteinThe physical association of casein kinase 2 with nucleolinFunctional analysis of phosphorylation at serine 532 of human c-Myb by MAP kinaseA nuclear casein kinase 2 activity is involved in early events of transcriptional activation induced by salicylic acid in tobaccoTargeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformationCritical functions for c-Myb at three checkpoints during thymocyte development.Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cellsMechanism of c-myc regulation by c-Myb in different cell lineages.Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain.a1/EBP: a leucine zipper protein that binds CCAAT/enhancer elements in the avian leukosis virus long terminal repeat enhancer.Reassessing the role of C-MYB in tumorigenesis.Transcriptional activation by the myb proteins requires a specific local promoter structure.D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo.Constitutive phosphorylation of I kappa B alpha by casein kinase II.REB1, a yeast DNA-binding protein with many targets, is essential for growth and bears some resemblance to the oncogene myb.Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivoDifferential requirement of a motif within the carboxyl-terminal domain of alpha-platelet-derived growth factor (alpha PDGF) receptor for PDGF focus forming activity chemotaxis, or growth.Regulation of transcription factor activity during cellular aging.The tyrosine phosphatase cdc25 selectively inhibits transcription of the Xenopus oocyte-type tRNAtyrC geneNuclear protein phosphorylation and growth control.Mammalian beta-polymerase promoter: phosphorylation of ATF/CRE-binding protein and regulation of DNA binding.Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication.Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.The interaction of ICP4 with cell/infected-cell factors and its state of phosphorylation modulate differential recognition of leader sequences in herpes simplex virus DNA.
P2860
Q24324093-CFDB2DB9-2280-413D-B2EB-BD7181A48F5BQ24339376-D0F5C2A2-4707-4E75-9DDF-CA5C0F27415AQ24555676-1EE7FC66-DFF6-4870-BED1-B48D93D4510AQ24564077-A46A61C6-0BBA-446B-A3FB-B7CFD7CB7694Q24597632-F0EB7E60-DBBE-46A0-8506-C680F22752D5Q24601947-DE1AC11B-09D5-4628-AB4B-A70071831748Q24611020-B72F0248-661E-43A1-937C-1A9D45857729Q24624946-DDDE0AEE-E7C0-4F2C-812E-9D683E46270EQ24626142-AAE43F39-E162-4450-AEC5-4937266D6199Q24682636-70EDB3A7-DA87-4D08-BF7D-47F8A6EACADBQ28201577-1E863773-4745-4DC0-880E-59B9DADF528CQ28256456-8D077069-A0C7-452F-A43C-2553001C877EQ28280074-EEC5B376-275C-4437-A8A9-01CBDF8D6B9CQ28282040-A2DD6C44-8D0D-4EF8-9643-047F07AB604DQ28299351-BEEE8A1B-857D-40CE-A387-747D762514AEQ28345748-1E76892E-F9DD-4378-91EE-FB8922A84BAEQ28349126-24A7DABC-DA39-4CE6-8F00-97335DE1DC0DQ28511612-F0FCE5BA-AD8C-4ACD-A2FD-07A384A152CBQ30433753-05A82796-F56C-43AD-B55C-30AE92EAC4ADQ30450271-F4A9BBC9-A7A9-45D3-B5E7-D747F869318AQ30450274-42BB891D-0A17-4380-A513-CDAEB78C7B45Q30453947-15CCE33B-86B8-493E-ABA7-BB16931DE40FQ30469099-DC05A594-08AA-42F8-8735-0630CDF9C087Q30984714-677CD0FD-CD39-467F-8E6D-127B5906B39AQ33667347-DA4C2A28-0045-4A53-B8B9-6135E59AB960Q33771556-4896EC11-FD35-4794-A694-71C9DEE38AF2Q33888005-9A588967-BA68-4CCC-BE1C-921A45510AA7Q33922153-52686EDB-F2D8-4BAF-A945-85A8F72F3A15Q33937736-02CBC68D-B61A-4021-8711-6C8F15521E2DQ33994452-72D079D1-040F-4A5D-B795-8ADBC1C5ED9CQ34065538-1CCD31D1-1A80-467D-B364-D7B4052941DFQ34123850-F58A1B28-AE30-4469-83A0-C44FA507C39CQ34307795-218AAD3E-1CAC-4DE6-942E-F223CD46F442Q34410714-5443A545-524E-468E-B94F-EBAE18760329Q35001874-9004F4D3-6A40-45DF-83D7-AF438E2FF6EDQ35450130-1FAF214A-6C5B-4CE5-A539-EF364FEE7C84Q35768643-7E221533-311E-4B3A-8E1D-DA8A5E70B7F0Q35854807-04DFB74F-D057-42DE-9C2F-7371E0B6F5E8Q35891194-2E63BA63-F529-40B8-9038-1EF04B9D5B0EQ35921488-D10A4CC3-514E-403F-BDF9-509B35FF2779
P2860
Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Myb DNA binding inhibited by p ...... d during oncogenic activation.
@en
type
label
Myb DNA binding inhibited by p ...... d during oncogenic activation.
@en
prefLabel
Myb DNA binding inhibited by p ...... d during oncogenic activation.
@en
P2093
P356
P1433
P1476
Myb DNA binding inhibited by p ...... d during oncogenic activation.
@en
P2093
Christenson E
Eisenman RN
Litchfield DW
P2888
P304
P356
10.1038/344517A0
P407
P577
1990-04-01T00:00:00Z
P6179
1051153689